tiprankstipranks
CNS Pharmaceuticals (CNSP)
NASDAQ:CNSP
US Market
CNSP
CNS Pharmaceuticals
RESEARCH TOOLSreports

CNS Pharmaceuticals (CNSP) Income Statement

1,088 Followers

CNS Pharmaceuticals Income Statement

Last quarter (Q4 2025), CNS Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, CNS Pharmaceuticals's net income was $-5.96M. See CNS Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Mar 24Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -3.31K$ -4.13K$ -11.76K$ -13.07K
Operating Expenses
$ 15.99M$ 14.90M$ 18.86M$ 14.92M$ 14.47M
Depreciation and Amortization
$ 0.00$ 3.31K$ 4.13K$ 11.76K$ 13.07K
EBITDA
$ -15.99M$ -14.84M$ -18.86M$ -15.26M$ -14.47M
Operating Income
$ -15.99M$ -14.90M$ -18.87M$ -14.93M$ -14.49M
Other Income/Expenses
$ 136.00K$ 44.14K$ 13.88K$ -341.17K$ -9.29K
Pretax Income
$ -15.85M$ -14.86M$ -18.85M$ -15.27M$ -14.50M
Net Income
$ -15.85M$ -14.86M$ -18.85M$ -15.27M$ -14.50M
Per Share Metrics
Basic EPS
$ -35.75$ -466.44$ -150.11K$ -336.50K$ -495.03K
Diluted EPS
$ -35.75$ -466.44$ -150.11K$ -336.50K$ -495.03K
Weighted Average Shares Outstanding
 443.37K 31.85K---
Weighted Average Shares Outstanding (Diluted)
 443.37K 31.85K---
Currency in USD

CNS Pharmaceuticals Earnings and Revenue History